Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer

RPSPC could serve as an independent prognostic factor for patients with URPC and might help identify those who benefit from chemotherapy.

Authors

Institutions

Publication Details

Journal
JCO Precision Oncology
Published
2026-01-01
DOI
https://doi.org/10.1200/po-25-00581
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer

Y. Liu, Xinkang Hu, Tan Xm, Keke Liang et al.
JCO Precision Oncology
Pancreatic and Hepatic Oncology Research
article

Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer

Y. Liu, Xinkang Hu, Tan Xm, Keke Liang, Zihang Zhang, Gongyan Liu
article en

Abstract

RPSPC could serve as an independent prognostic factor for patients with URPC and might help identify those who benefit from chemotherapy.

JCO Precision OncologyVol. 10(1)
China Medical University (CN)
Openalex Percentile: Top 93%
Pancreatic and Hepatic Oncology Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Radiopathomics Signature for Prognosis and Prediction of Chemotherapy Benefit in Unresectable Pancreatic Cancer — Y. Liu, Xinkang Hu, et al. · JCO Precision Oncology (2026) | TGRS Research Map | TGRS